The 3rd Annual Blood-Brain Barrier Summit is dedicated to helping drug developers enhance drug delivery across the Blood-Brain Barrier (BBB) to enable effective treatments for neurodegenerative diseases.
Now in its third year, this digital forum is the industry’s definitive blood-brain barrier conference, focused exclusively on evaluating innovative approaches to tackling the single biggest challenge for CNS drug developers. Whatever approach you are working on, we have collated a comprehensive variety of topics to showcase the latest scientific advances across this very competitive field.
Building on the success of last year’s meeting, this year’s program will uncover how leading companies and academics are working to enhance BBB penetration through the use of antibody therapies, nanoparticle engineering, AAV capsids, focused ultrasound, extracellular vesicles and more! New for this year we also explore the mechanisms of SARS-CoV-2 brain entry.
As we gather the best minds in this ever-challenging field, from the likes of AbbVie, Novartis, Roche, Merck and Ossianix, join this intimate forum to be part of the conversation focused on enhancing drug delivery across the blood-brain barrier and network and build meaningful partnerships with over 80 blood-brain barrier specialists.
The post 3rd Annual Blood-Brain Barrier Summit appeared first on .